WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals.
Product packaging and imagery are for representation purposes only and shall constitute the property of Azurity and all applicable affiliates.
The Information contained herein, including product information, is intended only for residents of the United States.
© 2019-2023 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners.
PP-FKS-US-0095
